Overholser and colleagues discuss the role of endocrine therapy to reduce risk for breast cancer, and cite interesting data from patients who developed premature
ovarian failure due to
ovarian irradiation or alkylating chemotherapeutic agents, which demonstrates that these patients were
at decreased risk for developing subsequent breast cancer.